MedPath

The Effect of Potatoes on Markers of Cardiometabolic Health

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Interventions
Dietary Supplement: Potato-based side dish
Dietary Supplement: Refined grain-based
Registration Number
NCT03495284
Lead Sponsor
Penn State University
Brief Summary

A 2-period randomized cross-over trial will be conducted to determine the effect of incorporating 1 medium size potato, compared to an isocaloric portion of refined grains, on fasting glucose levels, insulin sensitivity, blood pressure, lipids and lipoproteins, arterial stiffness, body weight, gut microbiome, and dietary intake.

Detailed Description

A 2-period randomized cross-over study will be conducted. Free-living subjects will be provided with a potato based side dish (equivalent to one medium sized potato) or an isocaloric refined grain based side dish every day for 4 weeks, in random order. The treatment periods will be separated by a minimum two-week break. Endpoint testing will be conducted over two days at baseline and the end of each diet period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Non-smoking
  • BMI > 20 and <40 kg/m2
  • Male or female
Exclusion Criteria
  • Diagnosed diabetes or fasting glucose >126 mg/dl
  • Hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)
  • Prescribed anti-hypertensive, lipid lowering or glucose lowering drugs
  • Established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease or inflammatory conditions
  • Use of supplements (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals and not willing to cease for the duration of the study
  • Pregnancy or lactation
  • Weight loss of >=10% of body weight within the 6 months prior to enrolling in the study
  • Smoking or use of any tobacco products

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Potato treatmentPotato-based side dishParticipants will be provided with one potato-based side dish, equivalent to one medium sized potato, every day for 4 weeks for incorporation into their self-selected diet. The potato-based side dish will be prepared at the Penn State Metabolic Kitchen. The potato side dish will consist of commonly consumed potato-based sides in the U.S. and there will be limited inclusion of ingredients high in saturated fat, refined sugars or sodium. French fries will not be provided. The variety of potatoes will represent consumption patterns in the U.S. including white, russet, yellow and red potatoes.
Refined grain treatmentRefined grain-basedParticipants will be provided with a calorie-matched refined grain-based side dish every day for 4 weeks for incorporation into their self-selected diet. The refined grain-based side dishes will be prepared at the Penn State Metabolic Kitchen and ingredients high in saturated fat, refined sugar or sodium will not be used. These will be sides commonly eaten in the U.S. (e.g. pasta made with white flour and white rice, white bread rolls). During this treatment, participants will be told not to consume potatoes.
Primary Outcome Measures
NameTimeMethod
Fasting blood glucose4 weeks
Secondary Outcome Measures
NameTimeMethod
Central blood pressure4 weeks
Triglycerides4 weeks
Total cholesterol4 weeks
Pulse Wave Velocity4 weeks
LDL cholesterol4 weeks
Diet quality measured by the Healthy Eating Index 20104 weeks
Change in microbiome compositionWeek 0; Week 2 of treatment period 1; Week 4 of treatment period 1; Week 2 of treatment 2; Week 4 of treatment 4
HDL cholesterol4 weeks
Augmentation index4 weeks
Change in fecal short chain fatty acid levelsWeek 0; Week 2 of treatment period 1; Week 4 of treatment period 1; Week 2 of treatment 2; Week 4 of treatment 4
Homeostasis Model of Assessment of Insulin Resistance4 weeks
Peripheral blood pressure4 weeks

Trial Locations

Locations (1)

Pennsylvania State University

🇺🇸

University Park, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath